Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL10633338 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL10783681 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL5163136 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL5907 | 0.93 | CA2 (0.56) | — | |
| Phosphoric Acid SCHEMBL8851940 | 0.93 | CA2 (0.56) | — | |
| Phosphoric Acid SCHEMBL3788505 | 0.93 | CA2 (0.56) | — | |
| Phosphoric Acid SCHEMBL36090 | 0.93 | CA2 (0.56) | — | |
| Phosphoric Acid SCHEMBL22 | 0.93 | — | — | |
| Phosphoric Acid SCHEMBL897840 | 0.93 | CA2 (0.56) | — | |
| Phosphoric Acid SCHEMBL1332284 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111423797-A | Water-based static conductive polyurea coating and preparation method thereof | 沈阳化工研究院有限公司 | 2020-07-17 | — | — | CN | claimed |
| CN-108586688-A | A kind of organic inorganic hybridization composite material and preparation method | 沈阳化工研究院有限公司 | 2018-09-28 | — | — | CN | claimed |
| CN-111334029-A | Preparation method of organic-inorganic hybrid composite material | 北京泰阁斯新材料科技有限公司 | 2020-06-26 | — | — | CN | disclosed |
| WO-2003101967-A1 | PREPARATION OF CHIRAL 1,2,3,4-TETRAHYDRO-6,7-DIALKOXY-3-ISOQUINOLINECARBOXYLIC ACID AND DERIVATIVES BY REACTING LEVODOPA WITH FORMALDEHYDE OR FORMALDEHYDE PRECURSORS | APTEX PHARMACHEM INC. (CA) | 2003-12-11 | — | — | WO | disclosed |
| US-6642384-B1 | Forming intermediate to moexipril; cyclizing levodopa with formaldehyde; protecting amine, alkylating phenols, esterifying carboxylic acid and optionally deprotecting | BRANTFORD CHEMICALS INC. (CA) | 2003-11-04 | — | — | US | disclosed |
| JP-2001342355-A | EXPANDABLE FIREPROOF COMPOSITION HAVING WATER RESISTANCE | OHBAYASHI CORP | 2001-12-14 | — | — | JP | disclosed |
| US-5368641-A | Modified 2,9-dimethylquinacridone pigments, process for their manufacture and a method for pigmenting or lacquer systems with these pigments | HOECHST AG (DE) | 1994-11-29 | — | — | US | disclosed |
| US-5294390-A | Cooling and drawing spun liquid crystal dope multifilaments through an air gap; desolventizing | THE DOW CHEMICAL COMPANY (US) | 1994-03-15 | — | — | US | disclosed |
| US-4336257-A | XANTHINE OXIDASE INHIBITORS OR ANTIHYPERTENSIVE AGENTS | MERCK & CO., INC. (US) | 1982-06-22 | — | — | US | disclosed |